| 06/03/2026 7:23 AM | Mesa Laboratories (724004) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/27/2026 7:00 AM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2026 8:04 AM | Kadia Siddhartha (1573666) Reporting Mesa Laboratories (724004) Issuer | Form 4/A | |
| 04/24/2026 9:41 AM | Kadia Siddhartha (1573666) Reporting Mesa Laboratories (724004) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/24/2026 9:49 AM | Kadia Siddhartha (1573666) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 11:11 AM | Long Path Smaller Companies Fund, LP (1748049) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G/A | |
| 03/27/2026 9:49 AM | Mesa Laboratories (724004) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 3:25 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/13/2026 3:40 PM | Long Path Smaller Companies Fund, LP (1748049) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G | |
| 03/10/2026 4:43 PM | Ladiwala Shiraz Shabanali (1715573) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:00 AM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MLAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/03/2026 7:01 AM | Mesa Laboratories (724004) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 12/05/2025 10:10 AM | Mesa Laboratories (724004) Issuer Sullivan John James (1305784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2025 3:51 PM | Mesa Laboratories (724004) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/31/2025 10:02 AM | Mesa Laboratories (724004) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 10/28/2025 2:08 PM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:46 PM | BlackRock, Inc. (2012383) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G/A | |
| 08/25/2025 2:13 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2025 1:37 PM | Ladiwala Shiraz Shabanali (1715573) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 1:20 PM | Mesa Laboratories (724004) Issuer Sullivan John James (1305784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:34 PM | Alltoft Jennifer Sadie (1769053) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:45 PM | Capone Mark Christopher (1352413) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:54 PM | Mesa Laboratories (724004) Issuer Tripeny R Tony (1339381) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 1:02 PM | Hall Shannon (1621222) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 1:03 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2025 7:00 AM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2025 7:01 AM | Mesa Laboratories (724004) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/18/2025 11:06 AM | BlackRock, Inc. (2012383) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G/A | |
| 07/11/2025 7:00 AM | Mesa Laboratories (724004) Filer | Form DEF 14A | |
| 06/25/2025 8:14 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 8:05 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 9:12 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 4:39 PM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 4:31 PM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 4:22 PM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 11:04 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 11:12 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 11:18 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 10:27 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 10:13 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 9:59 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
SpaceX is offering you shares. Don't take them. (Ad) SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $1.75 trillion valuation and 266 times earnings, you're buying in at the most expensive IPO in history - right when institutions who got in at $800 billion need someone to sell to.
Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure Colossus can't run without - and it's still trading at a fraction of its value. Skip the IPO trap and get the backdoor ticker for free |
| 06/16/2025 2:40 PM | Mesa Laboratories (724004) Subject Sakys John (1197710) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/16/2025 2:47 PM | Mesa Laboratories (724004) Subject Owens Gary M (1700671) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/16/2025 2:49 PM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |